The peptides themselves do not discriminate by sex, but the hormonal context differs significantly
A conceptual model of food cue reactivity, Nutrients (2023) Human drug compounding, Food and Drug Administration (2024) Compounding when drugs are on FDAs drug shortages list, Food and Drug Administration (2024) Your guide to FDA-approved medicines that contain semaglutide, Novo Nordisk FDA alerts health care providers, compounders, and patients of dosing errors associated with compounded injectable semaglutide products, Food and Drug Administration (2024) FDAs concerns with unapproved GLP-1 drugs used for weight loss, Food & Drug Administration (2024) Wegovy, DailyMed (2024) FDA warns patients and health care professionals not to use compounded drugs from Fullerton Wellness, Food and Drug Administration (2024) Novo Nordisk escalates legal actions to safeguard patients from potentially harmful compounded semaglutide drugs, Novo Nordisk (2024) FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize, Food and Drug Administration (2025) OFA v
1 2 Important safety information: Wegovy (semaglutide) is a prescription-only medication for the management of obesity and the reduction of cardiovascular risk
For detailed information on storage timelines, our peptide refrigerator storage guide covers everything you need to know
Provides a noticeable, early-stage reduction in sudden snacking urges and emotional sugar cravings, making it significantly easier to adapt to a clean, calorie-restricted diet from day one
The Wegovy 7.2mg dose is now available and is currently the highest strength weekly dose of Wegovy
